The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial

The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial

Background: Previous locoregional treatment could affect the response to nivolumab in platinum-refractory recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). The aim of this study is to evaluate the impact of the clinicopathological characteristics and previous treatment in predi...

Full description

Bibliographic Details
Main Authors: Andrea Botticelli, Silvia Mezi, Giulia Pomati, Paolo Sciattella, Bruna Cerbelli, Michela Roberto, Giulia Mammone, Alessio Cirillo, Alessandra Cassano, Carmela Di Dio, Alessio Cortellini, Laura Pizzuti, Graziana Ronzino, Massimiliano Salati, Patrizia Vici, Antonella Polimeni, Marco Carlo Merlano, Marianna Nuti, Paolo Marchetti
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Vaccines
Subjects:
squamous cell carcinoma
head and neck cancer
immunotherapy
nivolumab
locoregional treatment
Online Access:https://www.mdpi.com/2076-393X/8/2/191

Internet

https://www.mdpi.com/2076-393X/8/2/191

Similar Items